PLX PHARMA INC.

Profile

Company Names

PLX PHARMA INC.
PLX PHARMA INC

Addresses

8285 EL RIO STREET, SUITE 130, HOUSTON, TX 77054

8285 EL RIO STREET, SUITE 130, HOUSTON, TX 77054

Phone Numbers

713-842-1249

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

> 5 years ago

State Incorporated:

TEXAS

Total Amount Raised:

$26,571,243.00

Number of Funding Rounds:

6
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
6
2016-02-23 
$1,297,000.00 
$2,000,000.00 
$703,000.00 
Debt 
5
2013-05-28 
$9,000,000.00 
$9,000,000.00 
$0.00 
Equity 
4
2012-04-09 
$8,273,297.00 
$8,273,297.00 
$0.00 
Equity, Debt 
3
2011-07-31 
$2,893,965.00 
$7,000,000.00 
$4,106,035.00 
Equity 
2
2010-07-22 
$2,000,020.00 
$6,000,000.00 
$3,999,980.00 
Equity 
1
2009-01-06 
$3,106,961.00 
$3,106,961.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
DAVID 
 
ANDERSON 
DIRECTOR
PLX PHARMA INC   |  AIKO BIOTECHNOLOGY INC   |  EREWARDS INC   |  HEADSPROUT INC   |  FISKER AUTOMOTIVE INC   |  MOLECULAR DETECTION, INC.   |  FISKER HOLDINGS, INC.   |  PLX PHARMA INC.   |  E-REWARDS INC   |  NANOSPECTRA BIOSCIENCES INC   |  ALTA VENTURES MEXICO FUND I, L.P.   |  VISION SCIENCES INC /DE/   |  OFFERCLICK, INC.   |  838 OAK STREET LLC   |  CAMBURY APARTMENTS LLC   |  SYNERGY BIOMEDICAL, LLC   |  EMBERCLEAR CORP.   |  TRANSCENDENT CAFE LLC   |  ONE PINE APARTMENTS, LLC   |  LAKESHORE APARTMENTS, LLC   |  VBI VACCINES INC.   |  STEELWEDGE SOFTWARE INC   |  PLACESTER, INC.   |  CANADIAN INTERNATIONAL OIL CORP.   |  FIREHOLE CRAFT BREWING CO   |  FB2 SERVICES, INC.   |  ACTUALMEDS CORP   |  FPB FINANCIAL CORP   |  VBI VACCINES INC/BC   |  IBC ADVANCED ALLOYS CORP.   |  ZSX MEDICAL, LLC   |  NEXTSHIFT ROBOTICS INC.   |  BASANITE, INC.   |  LUNGLIFE AI, INC.   |  BETTO, INC.   |  ANABIOS CORP   |  VERNAL BIOSCIENCES, INC.   |  AVIDIAN GOLD CORP.   |  GREENIDGE GENERATION HOLDINGS INC.   |  CARMELL CORP
GARY 
 
BALKEMA 
DIRECTOR
PLX PHARMA INC.   |  PLX PHARMA INC.
TIM 
 
BLACK 
DIRECTOR
PLX PHARMA INC   |  PLX PHARMA INC.   |  TROLLEY VENTURE FUND I, LP
KIRK 
 
CALHOUN 
DIRECTOR
PLX PHARMA INC.   |  NEUROSIGMA, INC.   |  PLX PHARMA INC.   |  NANTHEALTH, INC.   |  AFAXYS, INC.
BOB 
 
CASALE 
DIRECTOR
PLX PHARMA INC.
NATASHA 
 
GIORDANO 
EXECUTIVE OFFICER, DIRECTOR
XANODYNE PHARMACEUTICALS INC   |  CLEARPOINT LEARNING SYSTEMS, INC.   |  HEALTHCARE CORP OF AMERICA   |  PLX PHARMA INC.   |  PLX PHARMA INC.   |  MATINAS BIOPHARMA HOLDINGS, INC.
JOHN 
 
HADDEN II 
DIRECTOR
PLX PHARMA INC.
DAVID 
 
JORDEN 
DIRECTOR, EXECUTIVE OFFICER
PLX PHARMA INC   |  PLX PHARMA INC.   |  CYTOMEDIX INC   |  NANOSPECTRA BIOSCIENCES INC   |  PLX PHARMA INC.   |  NUO THERAPEUTICS, INC.
LENARD 
 
LICHTENBERGER 
DIRECTOR
PLX PHARMA INC
LENARD 
M. 
LICHTENBERGER 
DIRECTOR
PLX PHARMA INC.
PETER 
 
MANN 
DIRECTOR
PLX PHARMA INC.   |  GS+A ENHANCED BOND FUND   |  ELI NUTRITION, INC.   |  AVIEMORE TECHNOLOGIES, INC.
UPENDRA 
 
MARATHI 
EXECUTIVE OFFICER
PLX PHARMA INC.   |  7 HILLS PHARMA INC.
GARY 
 
MOSSMAN 
EXECUTIVE OFFICER, DIRECTOR
PLX PHARMA INC.   |  GLYCOS BIOTECHNOLOGIES INC   |  PLX PHARMA INC.
ALEXANDER 
F. 
SEELENBERGER 
DIRECTOR
PLX PHARMA INC.
MICHAEL 
 
VALENTINO 
DIRECTOR
XANODYNE PHARMACEUTICALS INC   |  TRIA BEAUTY, INC.   |  PLX PHARMA INC.   |  ASSISTED 4 LIVING, INC.
RON 
 
ZIMMERMAN 
EXECUTIVE OFFICER
PLX PHARMA INC.
RONALD 
R. 
ZIMMERMAN 
EXECUTIVE OFFICER, DIRECTOR
PLX PHARMA INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2016-03-11
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
$1 - $1,000,000 
Debt 
2016-02-23 
2013-07-08
D
Link
PHARMACEUTICALS 
 
$1 - $1,000,000 
Equity 
2013-05-28 
2013-03-19
D
Link
PHARMACEUTICALS 
 
$1 - $1,000,000 
Equity, Debt 
2012-04-09 
2011-10-05
D
Link
PHARMACEUTICALS 
 
$1,000,001 - $5,000,000 
Equity 
2011-07-31 
2010-08-09
D
Link
PHARMACEUTICALS 
 
$1 - $1,000,000 
Equity 
2010-07-22 
2009-07-09
D
Link
PHARMACEUTICALS 
 
$1 - $1,000,000 
Equity 
2009-01-06 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#